Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.73% Nasdaq Up0.83%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM

5.02 Up 0.01(0.20%) Jun 17, 4:00PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 3,754   5,000   33  
Cost of Revenue -   -   -  
Gross Profit 3,754   5,000   33  
Operating Expenses
Research Development29,185  22,563  14,433  
Selling General and Administrative9,175  8,303  7,005  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (34,606) (25,866) (21,405)
Income from Continuing Operations
Total Other Income/Expenses Net(7,490)5,984  (3,182)
Earnings Before Interest And Taxes(42,096)(19,882)(24,587)
Interest Expense1,855  259   -  
Income Before Tax(43,951)(20,141)(24,587)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(43,951)(20,141)(24,587)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (43,951) (20,141) (24,587)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (43,951) (20,141) (24,587)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.